83 related articles for article (PubMed ID: 3313415)
1. Nocloprost, a novel prostanglandin E2 analog: significant reduction of aspirin induced grastrointestinal lesions in man.
Dammann HG; Dreyer M; Walter TA; Müller P; Simon B; Wabnitz RW
Prog Clin Biol Res; 1987; 242():295-8. PubMed ID: 3313415
[No Abstract] [Full Text] [Related]
2. Endoscopic evaluation of the effects of aspirin, buffered aspirin, and enteric-coated aspirin on gastric and duodenal mucosa.
Lanza FL; Royer GL; Nelson RS
N Engl J Med; 1980 Jul; 303(3):136-8. PubMed ID: 6966762
[No Abstract] [Full Text] [Related]
3. [Endoscopic changes in the stomach and duodenal mucosa caused by microdose acetylsalicylic acid therapy and their prevention--editorial].
Ehrmann J; Procházka V; Konecný M; Spacek M; Urbánek K
Vnitr Lek; 2007 Oct; 53(10):1024-8. PubMed ID: 18072422
[No Abstract] [Full Text] [Related]
4. Gastric protection by nocloprost against aspirin damage in humans. Possible role of epidermal growth factor.
Konturek SJ; Konturek JW; Kwiecien N; Obtułowicz W; Oleksy J; Hebzda Z; Amon I
Scand J Gastroenterol; 1991 Mar; 26(3):231-6. PubMed ID: 1853145
[TBL] [Abstract][Full Text] [Related]
5. Prevention of acute aspirin-induced gastric mucosal injury by 15-R-15 methyl prostaglandin E2: an endoscopic study.
Gilbert DA; Surawicz CM; Silverstein FE; Weinberg CR; Saunders DR; Feld AD; Sanford RL; Bergman D; Washington P
Gastroenterology; 1984 Feb; 86(2):339-45. PubMed ID: 6360786
[TBL] [Abstract][Full Text] [Related]
6. Effects of alendronate on gastric and duodenal mucosa.
Lanza F; Rack MF; Simon TJ; Lombardi A; Reyes R; Suryawanshi S
Am J Gastroenterol; 1998 May; 93(5):753-7. PubMed ID: 9625122
[TBL] [Abstract][Full Text] [Related]
7. [Protective effect of omeprazole on gastric lesions induced by a single dose of aspirin in man].
Bigard MA
Gastroenterol Clin Biol; 1988 Oct; 12(10):770-1. PubMed ID: 3065128
[No Abstract] [Full Text] [Related]
8. Nocloprost, a unique PGE2 analog, with local gastroprotective and ulcer healing activity.
Konturek SJ; Brzozowski T; Drozdowicz D; Krzyzek E; Garlicki J; Majka J; Amon I
Adv Prostaglandin Thromboxane Leukot Res; 1991; 21B():793-7. PubMed ID: 1825413
[No Abstract] [Full Text] [Related]
9. Ranitidine protects against gastroduodenal mucosal damage associated with chronic aspirin therapy.
Berkowitz JM; Rogenes PR; Sharp JT; Warner CW
Arch Intern Med; 1987 Dec; 147(12):2137-9. PubMed ID: 3689065
[TBL] [Abstract][Full Text] [Related]
10. Endoscopic evaluation of the comparative effects of acetylsalicylic acid and choline magnesium trisalicylate on human gastric and duodenal mucosa.
Kilander A; Dotevall G
Br J Rheumatol; 1983 Feb; 22(1):36-40. PubMed ID: 6337663
[TBL] [Abstract][Full Text] [Related]
11. [Protective effect of an antacid against acetylsalicylic acid].
Müller P; Marinis E; Dammann HG; Simon B
Arzneimittelforschung; 1989 Sep; 39(9):1169-70. PubMed ID: 2590271
[TBL] [Abstract][Full Text] [Related]
12. The effect of 15(R)-15-methyl prostaglandin E2 (Arbacet) on the healing of aspirin or nonsteroidal antiinflammatory drug-induced gastric mucosal lesions: an endoscopic study.
Jaszewski R; Crane SA
Am J Gastroenterol; 1987 Dec; 82(12):1271-4. PubMed ID: 3318402
[TBL] [Abstract][Full Text] [Related]
13. [Prostaglandin E1 (misoprostol) and S-adenosylmethionine in the prevention of hemorrhagic gastritis induced by aspirin in the human. Endoscopic, histologic and histochemical study].
Laudanno OM; Finkelstein D; Capdepon E
Acta Gastroenterol Latinoam; 1984; 14(4):289-93. PubMed ID: 6399655
[TBL] [Abstract][Full Text] [Related]
14. Effects of ibuprofen lysinate and acetylsalicylic acid on gastric and duodenal mucosa. Randomized single-blind placebo-controlled endoscopic study in healthy volunteers.
Müller P; Simon B
Arzneimittelforschung; 1994 Jul; 44(7):840-3. PubMed ID: 7945519
[TBL] [Abstract][Full Text] [Related]
15. The effects of flurbiprofen, aspirin, cimetidine, and antacids on the gastric and duodenal mucosa of normal volunteers. An endoscopic and photographic study.
Friedman H; Seckman CE; Schwartz JH; Lanza FL; Royer GL; Stubbs CM
J Clin Pharmacol; 1989 Jun; 29(6):559-62. PubMed ID: 2787809
[TBL] [Abstract][Full Text] [Related]
16. [Endoscopic changes in the stomach and duodenal mucosa caused by minidose acetylsalicylic acid therapy and their prevention].
Novotný I; Díte P; Kunovská M; Münzová H
Vnitr Lek; 2007 Oct; 53(10):1053-6. PubMed ID: 18072429
[TBL] [Abstract][Full Text] [Related]
17. [Participation of gastroduodenal mucosa prostaglandins in the anti-ulcer effect of venter].
Vysotskaia RA; Loginov AS; Vasil'ev IuV; Il'chenko AA; Pechkovskaia OI; Bendikov EA
Biull Eksp Biol Med; 1998 Jul; 126(7):90-3. PubMed ID: 9777208
[No Abstract] [Full Text] [Related]
18. [Effect of calcium channel blockers on the functional and morphologic conditions of the stomach and duodenum].
Orlov VA; Shamkhatov ZM
Klin Med (Mosk); 1989 Mar; 67(3):24-30. PubMed ID: 2664339
[No Abstract] [Full Text] [Related]
19. Clinical aspects of gastric cytoprotection.
Konturek SJ
Gastroenterol Clin Biol; 1985; 9(12 Pt 2):48-52. PubMed ID: 3914440
[No Abstract] [Full Text] [Related]
20. Co-administration of nitric oxide-aspirin (NCX-4016) and aspirin prevents platelet and monocyte activation and protects against gastric damage induced by aspirin in humans.
Fiorucci S; Mencarelli A; Meneguzzi A; Lechi A; Renga B; del Soldato P; Morelli A; Minuz P
J Am Coll Cardiol; 2004 Aug; 44(3):635-41. PubMed ID: 15358033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
